The Valley Desk

ReviewJournal for immunotherapy of cancerPublished

Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Journal for immunotherapy of cancer
Published
Subject terms
Humans; Neoplasms; Immunotherapy, Adoptive; Clinical Trials as Topic; Genetic Therapy; Cell- and Tissue-Based Therapy; Gene Editing; Gene therapy; Solid tumor; Adoptive Cell Therapy - Act; Chimeric Antigen Receptor - Car; T Cell Receptor - Tcr
PubMed ID
40480658
PubMed Central ID
PMC12142127
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal